Botanix Pharmaceuticals Limited

Informe acción ASX:BOT

Capitalización de mercado: AU$393.8m

Salud financiera de hoja de balance de Botanix Pharmaceuticals

Salud financiera controles de criterios 5/6

Botanix Pharmaceuticals tiene un patrimonio de los accionistas total de A$45.4M y una deuda total de A$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son A$47.7M y A$2.3M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

AU$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoAU$18.31m
PatrimonioAU$45.39m
Total pasivoAU$2.29m
Activos totalesAU$47.68m

Actualizaciones recientes sobre salud financiera

Recent updates

Will Botanix Pharmaceuticals (ASX:BOT) Spend Its Cash Wisely?

Mar 21
Will Botanix Pharmaceuticals (ASX:BOT) Spend Its Cash Wisely?

Here's Why We're Watching Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

Sep 06
Here's Why We're Watching Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

Botanix Pharmaceuticals (ASX:BOT) Will Have To Spend Its Cash Wisely

Jan 03
Botanix Pharmaceuticals (ASX:BOT) Will Have To Spend Its Cash Wisely

Can Botanix Pharmaceuticals (ASX:BOT) Afford To Invest In Growth?

Sep 05
Can Botanix Pharmaceuticals (ASX:BOT) Afford To Invest In Growth?

Here's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

May 10
Here's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

We're Not Very Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate

Jan 12
We're Not Very Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate

We Think Botanix Pharmaceuticals (ASX:BOT) Can Afford To Drive Business Growth

Jul 01
We Think Botanix Pharmaceuticals (ASX:BOT) Can Afford To Drive Business Growth

We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Mar 18
We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

The Botanix Pharmaceuticals (ASX:BOT) Share Price Has Gained 81% And Shareholders Are Hoping For More

Jan 24
The Botanix Pharmaceuticals (ASX:BOT) Share Price Has Gained 81% And Shareholders Are Hoping For More

We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Nov 30
We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (A$21.8M) de BOT superan a sus pasivos a corto plazo (A$2.3M).

Pasivo a largo plazo: BOT no tiene pasivos a largo plazo.


Historial y análisis de deuda-patrimonio

Nivel de deuda: BOT está libre de deudas.

Reducción de la deuda: BOT no ha tenido ninguna deuda en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: BOT tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: BOT dispone de suficiente cash runway para 1.3 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 10.9% cada año.


Descubre empresas con salud financiera